The American College of Rheumatology/European League Against Rheumatism criteria for the classification of rheumatoid arthritis: A game changer

Arthritis and Rheumatism

Volumn 62, Issue 9, 2010, Pages 2592-2594

  Cohen, Stanley ^a,b   Emery, Paul ^c,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b American College of Rheumatology   (United States)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d European League Against Rheumatism   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; METHOTREXATE; ANTIRHEUMATIC AGENT;

CHRONICITY; COHORT ANALYSIS; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE COURSE; EARLY INTERVENTION; ECHOGRAPHY; EDITORIAL; FACE VALIDITY; GOUT; HUMAN; JOINT RADIOGRAPHY; MEDICAL SOCIETY; MYOSITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PREDICTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; SCLERODERMA; SCORING SYSTEM; SEROLOGY; SYNOVITIS; VASCULITIS; ARTHRITIS, RHEUMATOID; CLASSIFICATION; CLINICAL TRIAL (TOPIC); CONSENSUS DEVELOPMENT; EUROPE; INTERNATIONAL COOPERATION; NOMENCLATURE; NORTH AMERICA;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS AS TOPIC; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; EUROPE; HUMANS; INTERNATIONAL COOPERATION; NORTH AMERICA; SOCIETIES, MEDICAL; TERMINOLOGY AS TOPIC;

EID: 77956379677     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27583     Document Type: Editorial

References (8)

1. Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C, et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis 2008;67:1360-4.
2. Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C, et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum 2008;59:1371-7.
3. Aletha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 Rheumatoid Arthritis Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569-81.
4. Aletha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 Rheumatoid Arthritis Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69:1580-88.
5. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
6. Van der Helm-van Mil AH, Detert J, le Cessie S, Filer A, Bastian H, Burmester GR, et al. Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: moving toward individualized treatment decision-making. Arthritis Rheum 2008;58:2241-7.
7. Aggarwal R, Liao K, Nair R, Ringold S, Costenbader KH. Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. Arthritis Rheum 2009;61:1472-83.
8. Emery P. The Dunlop-Dottridge Lecture: prognosis in inflammatory arthritis: the value of HLA genotyping and the oncological analogy. J Rheumatol 1997;24:1436-42. (Pubitemid 27353394)